Analysis and Commentary 5/21/21 Analysis and Commentary 5/21/21 Messaging for Upcoming Senate Hill Days Read More Advocacy at a Glance 5/21/21 Advocacy at a Glance 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Analysis and Commentary 6/26/20 Analysis and Commentary 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More Advocacy at a Glance 3/27/20 Advocacy at a Glance 3/27/20 Advocacy at a Glance Read More Advocacy at a Glance 3/19/20 Advocacy at a Glance 3/19/20 Advocacy at a Glance Read More Advocacy at a Glance 3/13/20 Advocacy at a Glance 3/13/20 Advocacy at a Glance Read More Analysis and Commentary 2/27/20 Analysis and Commentary 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More Advocacy at a Glance 2/21/20 Advocacy at a Glance 2/21/20 Advocacy at a Glance Read More Advocacy at a Glance 2/7/20 Advocacy at a Glance 2/7/20 Advocacy at a Glance Read More Advocacy at a Glance 1/25/20 Advocacy at a Glance 1/25/20 Advocacy at a Glance Read More Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More Analysis and Commentary 12/16/19 Analysis and Commentary 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More Analysis and Commentary 8/2/19 Analysis and Commentary 8/2/19 From Budget Deal to FY 20 Appropriations: Reasons for Optimism? Read More Analysis and Commentary 7/12/19 Analysis and Commentary 7/12/19 Education and Advocacy for FDA Is a Year-Round Priority Read More Advocacy at a Glance 4/12/19 Advocacy at a Glance 4/12/19 Advocacy at a Glance Read More Advocacy at a Glance 3/22/19 Advocacy at a Glance 3/22/19 Advocacy at a Glance Read More Advocacy at a Glance 3/16/19 Advocacy at a Glance 3/16/19 Advocacy at a Glance Read More Advocacy at a Glance 3/8/19 Advocacy at a Glance 3/8/19 Advocacy at a Glance Read More Analysis and Commentary 2/22/19 Analysis and Commentary 2/22/19 Four More Qs and Four More As Read More Older Posts
Analysis and Commentary 5/21/21 Analysis and Commentary 5/21/21 Messaging for Upcoming Senate Hill Days Read More
Advocacy at a Glance 5/21/21 Advocacy at a Glance 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Analysis and Commentary 6/26/20 Analysis and Commentary 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More
Analysis and Commentary 2/27/20 Analysis and Commentary 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More
Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More
Analysis and Commentary 12/16/19 Analysis and Commentary 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More
Analysis and Commentary 8/2/19 Analysis and Commentary 8/2/19 From Budget Deal to FY 20 Appropriations: Reasons for Optimism? Read More
Analysis and Commentary 7/12/19 Analysis and Commentary 7/12/19 Education and Advocacy for FDA Is a Year-Round Priority Read More
Analysis and Commentary 2/22/19 Analysis and Commentary 2/22/19 Four More Qs and Four More As Read More
